Literature DB >> 23328259

Reduction of immunocompetent T cells followed by prolonged lymphopenia in severe sepsis in the elderly.

Shigeaki Inoue1, Kyoko Suzuki-Utsunomiya, Yoshinori Okada, Takayuki Taira, Yumi Iida, Naoya Miura, Tomoatsu Tsuji, Takeshi Yamagiwa, Seiji Morita, Tomoki Chiba, Takehito Sato, Sadaki Inokuchi.   

Abstract

OBJECTIVE: To investigate the immunological changes caused by severe sepsis in elderly patients.
DESIGN: One-year, prospective observational study.
SETTING: Emergency department and intensive care unit of a single university hospital. PATIENTS: Seventy-three patients with severe sepsis and 72 healthy donors.
MEASUREMENTS AND MAIN RESULTS: In elderly septic patients (aged 65 yr and over), 3-month survival was significantly reduced compared with that for adult patients (18-64 yr) (60% vs. 89%, p < 0.01). We found that lymphopenia was prolonged for at least 21 days in elderly nonsurvivors of sepsis, while the number of lymphocytes recovered in both adult and elderly survivors of sepsis. In order to examine the immunological status of septic patients, blood samples were collected within 48 hrs of diagnosis of severe sepsis, and peripheral blood mononuclear cells were purified for flow cytometric analysis. T cell levels were significantly reduced in both adult and elderly septic patients, compared with those in healthy donors (56% and 57% reduction, respectively). Interestingly, the immunocompetent CD28+ subset of CD4+ T cells decreased, whereas the immunosuppressive PD-1+ T cells and the percentage of regulatory T cells (CD4+ T cells that are both Foxp3+ and CD25+) increased in elderly patients, especially nonsurvivors, presumably reflecting the initial signs of immunosuppression.
CONCLUSION: Reduction of immunocompetent T cells followed by prolonged lymphopenia may be associated with poor prognosis in elderly septic patients.

Entities:  

Mesh:

Year:  2013        PMID: 23328259     DOI: 10.1097/CCM.0b013e318274645f

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  56 in total

Review 1.  Immunometabolism: Another Road to Sepsis and Its Therapeutic Targeting.

Authors:  Vijay Kumar
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

Review 2.  Immunopathogenesis of abdominal sepsis.

Authors:  Georg F Weber; Filip K Swirski
Journal:  Langenbecks Arch Surg       Date:  2014-01       Impact factor: 3.445

3.  Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559).

Authors:  Richard S Hotchkiss; Elizabeth Colston; Sachin Yende; Derek C Angus; Lyle L Moldawer; Elliott D Crouser; Greg S Martin; Craig M Coopersmith; Scott Brakenridge; Florian B Mayr; Pauline K Park; June Ye; Ian M Catlett; Ihab G Girgis; Dennis M Grasela
Journal:  Crit Care Med       Date:  2019-05       Impact factor: 7.598

Review 4.  Endogenous IgG hypogammaglobulinaemia in critically ill adults with sepsis: systematic review and meta-analysis.

Authors:  Manu Shankar-Hari; Nicholas Culshaw; Benjamin Post; Eduardo Tamayo; David Andaluz-Ojeda; Jesús F Bermejo-Martín; Sebastian Dietz; Karl Werdan; Richard Beale; Jo Spencer; Mervyn Singer
Journal:  Intensive Care Med       Date:  2015-05-14       Impact factor: 17.440

5.  Glucocorticoids regulate the proliferation of T cells via miRNA-155 in septic shock.

Authors:  Ying Chen; Guang Wang; Zhongmin Liu; Shiji Wang; Yushan Wang
Journal:  Exp Ther Med       Date:  2016-10-20       Impact factor: 2.447

Review 6.  Sepsis and Other Infectious Disease Emergencies in the Elderly.

Authors:  Stephen Y Liang
Journal:  Emerg Med Clin North Am       Date:  2016-08       Impact factor: 2.264

7.  Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial.

Authors:  Bruno Francois; Robin Jeannet; Thomas Daix; Andrew H Walton; Matthew S Shotwell; Jacqueline Unsinger; Guillaume Monneret; Thomas Rimmelé; Teresa Blood; Michel Morre; Anne Gregoire; Gail A Mayo; Jane Blood; Scott K Durum; Edward R Sherwood; Richard S Hotchkiss
Journal:  JCI Insight       Date:  2018-03-08

Review 8.  A novel role for coinhibitory receptors/checkpoint proteins in the immunopathology of sepsis.

Authors:  Eleanor A Fallon; Bethany M Biron-Girard; Chun-Shiang Chung; Joanne Lomas-Neira; Daithi S Heffernan; Sean F Monaghan; Alfred Ayala
Journal:  J Leukoc Biol       Date:  2018-02-02       Impact factor: 4.962

Review 9.  Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Nat Rev Immunol       Date:  2013-11-15       Impact factor: 53.106

10.  Persistent lymphopenia after diagnosis of sepsis predicts mortality.

Authors:  Anne M Drewry; Navdeep Samra; Lee P Skrupky; Brian M Fuller; Stephanie M Compton; Richard S Hotchkiss
Journal:  Shock       Date:  2014-11       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.